Progress in the safety of chimeric antigen receptor T cells therapy / 白血病·淋巴瘤
Journal of Leukemia & Lymphoma
;
(12): 65-67, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-882240
ABSTRACT
Chimeric antigen receptor T cells (CAR-T) therapy is progressing rapidly, and its safety has been widely concerned. At the 62nd American Society of Hematology Annual Meeting, a series of reports on the mechanism, predictive indicators and treatment strategies of major adverse reactions were carried out. These reports have certain guiding significance for comprehensively improving the safety of CAR-T therapy.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Leukemia & Lymphoma
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS